Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland

Turning scientific discoveries into better treatments...

University of Queensland

The University of Queensland Diamantina Institute (UQDI) has a strong focus on translational research in both the clinical and basic science of cancer and disorders of immune regulation. The Instute comprises a modern research facility with lead by Professor Matthew Brown, and hosts over 200 researchers, students and support staff. It lays claim to global, world-changing discoveries, such as the world’s first cervical cancer vaccine.

UQDI is based at the Translational Research Institute (TRI) on the Princess Alexandra Hospital campus, which facilitates strong clinical interactions. The TRI provides world-class facilities, which allow researchers to conduct cutting edge research.

The TRI also affords UQDI researchers the opportunity for a much greater collaborative research environment, allowing our researchers to focus their efforts on turning their scientific discoveries into better treatments for diseases including a variety of cancers, osteoporosis, arthritis and other autoimmune diseases.

Upcoming Events

Jul 19, 2020 - Jul 21, 2020 ANZUP 2020 Annual Scientific Meeting
Adelaide Convention Centre, South Australia
Aug 18, 2020 - Aug 21, 2020 PA Hospital Health Symposium
Russell Strong Auditorium, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba
Aug 21, 2020 - Aug 23, 2020 21st Asia-Pacific Prostate Cancer Conference
Melbourne Convention and Exhibition Centre, Victoria
Sep 29, 2020 - Oct 02, 2020 ComBio 2020
Melbourne Convention and Exhibition Centre, Victoria
Nov 11, 2020 - Nov 13, 2020 COSA Annual Scientific Meeting
Brisbane Convention and Exhibition Centre, Queensland